Whitehawk Therapeutics prices USD 87.5 million PIPE at USD 3.92 per share

Whitehawk Therapeutics

Whitehawk Therapeutics

WHWK

0.00
  • Whitehawk Therapeutics announced an $87.5 million PIPE financing through an unregistered sale of common stock and pre-funded warrants.
  • Deal includes 4,330,866 common shares priced at USD 3.92 per share.
  • Also selling pre-funded warrants for 17,991,021 shares priced at USD 3.92 per warrant, with an exercise price of USD 0.0001 per share.
  • Closing expected May 14, 2026.
  • Proceeds earmarked for working capital, general corporate purposes, ADC pipeline development; cash runway expected into second half of 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605130800PR_NEWS_USPR_____LA58360) on May 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.